| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | cortisone | 0.3633 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.4503 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.5863 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.5873 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.5932 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.6376 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.6424 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.6638 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.6705 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.7270 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.7515 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.7559 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.7749 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.7924 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.7984 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8012 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8017 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8045 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8066 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8066 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8078 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8100 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8160 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8193 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8237 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8248 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8254 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8301 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8346 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8346 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8429 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8434 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8525 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8536 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8564 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8638 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8667 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8674 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8698 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8710 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8734 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8737 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8779 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8789 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8816 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8834 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8883 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8895 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.8997 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9018 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9020 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9046 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9060 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9070 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9082 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9091 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9133 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9135 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9173 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9179 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9184 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9192 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9239 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9247 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9314 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9415 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9447 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9464 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9479 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9501 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9507 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9515 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9569 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9591 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9665 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9691 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9695 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9705 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9728 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9735 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9737 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9741 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9745 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9817 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9856 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9864 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9885 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9932 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9962 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9962 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9988 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9995 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 0.9999 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0000 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0005 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0024 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0049 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0061 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0118 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0139 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0140 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0151 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0158 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0169 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0174 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0185 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0205 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0207 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0225 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0263 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0279 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0297 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0299 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0334 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0392 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0397 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0415 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0422 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0469 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0487 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0510 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0510 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0540 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0568 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0597 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0647 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0731 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0784 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0791 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0827 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0833 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0866 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0892 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0909 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0939 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0976 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.0991 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1001 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1014 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1086 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1153 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1184 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1197 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1203 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1214 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1226 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1227 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1260 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1294 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1360 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1384 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1407 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1432 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1462 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1470 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1497 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1609 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1745 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1783 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1807 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1898 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1925 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1930 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1948 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.1991 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.2071 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.2247 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.2250 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.2604 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.2650 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.2657 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.2787 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.2824 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.2994 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.3058 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.3081 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.3212 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.3374 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.3457 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.3956 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.3993 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.3993 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.4281 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.4290 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.4321 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.4356 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | cortisone | 1.5085 | scaled units | Low-Dose | -0.5HR |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|